Prevalence and co-existence of locomotive syndrome, sarcopenia, and frailty: the third survey of Research on Osteoarthritis/Osteoporosis Against Disability (ROAD) study
This study aimed to estimate the prevalence of locomotive syndrome, sarcopenia, and frailty and clarify their co-existence in a population-based cohort. The third survey of Research on Osteoarthritis/Osteoporosis Against Disability (ROAD) study was conducted between 2012 and 2013, examining 963 subj...
Saved in:
Published in | Journal of bone and mineral metabolism Vol. 37; no. 6; pp. 1058 - 1066 |
---|---|
Main Authors | , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
Tokyo
Springer Japan
01.11.2019
Springer Nature B.V |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | This study aimed to estimate the prevalence of locomotive syndrome, sarcopenia, and frailty and clarify their co-existence in a population-based cohort. The third survey of Research on Osteoarthritis/Osteoporosis Against Disability (ROAD) study was conducted between 2012 and 2013, examining 963 subjects (aged ≥ 60 years; 321 men, 642 women). Locomotive syndrome, sarcopenia, and frailty were defined using three tests proposed by Japanese Orthopaedic Association, Asian Working Group for Sarcopenia criteria, and Fried’s definition, respectively. Prevalence of locomotive syndrome stages 1 and 2 were 81.0% (men, 80.4%; women, 81.3%) and 34.1% (men, 30.5%; women, 35.8%), respectively, and those of sarcopenia and frailty were 8.7% (men, 9.7%; women, 8.3%) and 4.5% (men, 2.8%; women, 5.3%), respectively. Locomotive syndrome stage 1, sarcopenia, and frailty co-existed in 2.1%; 6.5% had locomotive syndrome stage 1 and sarcopenia, 2.4% had locomotive syndrome stage 1 and frailty, while none had sarcopenia and frailty. Locomotive syndrome stage 1 presented alone in 70.0%, sarcopenia in 0.1%, and no frailty. The remaining 18.9% had none of these conditions. Co-existence of locomotive syndrome stage 2, sarcopenia, and frailty was observed in 2.0%; 5.0% had locomotive syndrome stage 2 and sarcopenia, 2.2% had locomotive syndrome stage 2 and frailty, and 0.1% had sarcopenia and frailty. Locomotive syndrome stage 2, sarcopenia, and frailty alone, presented in 24.9%, 1.7%, and 0.2%, respectively. The remaining 64.0% had none of these conditions. Most subjects with sarcopenia and/or frailty also had locomotive syndrome. Preventing locomotive syndrome may help prevent frailty and sarcopenia and subsequent disability. |
---|---|
AbstractList | This study aimed to estimate the prevalence of locomotive syndrome, sarcopenia, and frailty and clarify their co-existence in a population-based cohort. The third survey of Research on Osteoarthritis/Osteoporosis Against Disability (ROAD) study was conducted between 2012 and 2013, examining 963 subjects (aged ≥ 60 years; 321 men, 642 women). Locomotive syndrome, sarcopenia, and frailty were defined using three tests proposed by Japanese Orthopaedic Association, Asian Working Group for Sarcopenia criteria, and Fried’s definition, respectively. Prevalence of locomotive syndrome stages 1 and 2 were 81.0% (men, 80.4%; women, 81.3%) and 34.1% (men, 30.5%; women, 35.8%), respectively, and those of sarcopenia and frailty were 8.7% (men, 9.7%; women, 8.3%) and 4.5% (men, 2.8%; women, 5.3%), respectively. Locomotive syndrome stage 1, sarcopenia, and frailty co-existed in 2.1%; 6.5% had locomotive syndrome stage 1 and sarcopenia, 2.4% had locomotive syndrome stage 1 and frailty, while none had sarcopenia and frailty. Locomotive syndrome stage 1 presented alone in 70.0%, sarcopenia in 0.1%, and no frailty. The remaining 18.9% had none of these conditions. Co-existence of locomotive syndrome stage 2, sarcopenia, and frailty was observed in 2.0%; 5.0% had locomotive syndrome stage 2 and sarcopenia, 2.2% had locomotive syndrome stage 2 and frailty, and 0.1% had sarcopenia and frailty. Locomotive syndrome stage 2, sarcopenia, and frailty alone, presented in 24.9%, 1.7%, and 0.2%, respectively. The remaining 64.0% had none of these conditions. Most subjects with sarcopenia and/or frailty also had locomotive syndrome. Preventing locomotive syndrome may help prevent frailty and sarcopenia and subsequent disability. This study aimed to estimate the prevalence of locomotive syndrome, sarcopenia, and frailty and clarify their co-existence in a population-based cohort. The third survey of Research on Osteoarthritis/Osteoporosis Against Disability (ROAD) study was conducted between 2012 and 2013, examining 963 subjects (aged ≥ 60 years; 321 men, 642 women). Locomotive syndrome, sarcopenia, and frailty were defined using three tests proposed by Japanese Orthopaedic Association, Asian Working Group for Sarcopenia criteria, and Fried’s definition, respectively. Prevalence of locomotive syndrome stages 1 and 2 were 81.0% (men, 80.4%; women, 81.3%) and 34.1% (men, 30.5%; women, 35.8%), respectively, and those of sarcopenia and frailty were 8.7% (men, 9.7%; women, 8.3%) and 4.5% (men, 2.8%; women, 5.3%), respectively. Locomotive syndrome stage 1, sarcopenia, and frailty co-existed in 2.1%; 6.5% had locomotive syndrome stage 1 and sarcopenia, 2.4% had locomotive syndrome stage 1 and frailty, while none had sarcopenia and frailty. Locomotive syndrome stage 1 presented alone in 70.0%, sarcopenia in 0.1%, and no frailty. The remaining 18.9% had none of these conditions. Co-existence of locomotive syndrome stage 2, sarcopenia, and frailty was observed in 2.0%; 5.0% had locomotive syndrome stage 2 and sarcopenia, 2.2% had locomotive syndrome stage 2 and frailty, and 0.1% had sarcopenia and frailty. Locomotive syndrome stage 2, sarcopenia, and frailty alone, presented in 24.9%, 1.7%, and 0.2%, respectively. The remaining 64.0% had none of these conditions. Most subjects with sarcopenia and/or frailty also had locomotive syndrome. Preventing locomotive syndrome may help prevent frailty and sarcopenia and subsequent disability. This study aimed to estimate the prevalence of locomotive syndrome, sarcopenia, and frailty and clarify their co-existence in a population-based cohort. The third survey of Research on Osteoarthritis/Osteoporosis Against Disability (ROAD) study was conducted between 2012 and 2013, examining 963 subjects (aged ≥ 60 years; 321 men, 642 women). Locomotive syndrome, sarcopenia, and frailty were defined using three tests proposed by Japanese Orthopaedic Association, Asian Working Group for Sarcopenia criteria, and Fried's definition, respectively. Prevalence of locomotive syndrome stages 1 and 2 were 81.0% (men, 80.4%; women, 81.3%) and 34.1% (men, 30.5%; women, 35.8%), respectively, and those of sarcopenia and frailty were 8.7% (men, 9.7%; women, 8.3%) and 4.5% (men, 2.8%; women, 5.3%), respectively. Locomotive syndrome stage 1, sarcopenia, and frailty co-existed in 2.1%; 6.5% had locomotive syndrome stage 1 and sarcopenia, 2.4% had locomotive syndrome stage 1 and frailty, while none had sarcopenia and frailty. Locomotive syndrome stage 1 presented alone in 70.0%, sarcopenia in 0.1%, and no frailty. The remaining 18.9% had none of these conditions. Co-existence of locomotive syndrome stage 2, sarcopenia, and frailty was observed in 2.0%; 5.0% had locomotive syndrome stage 2 and sarcopenia, 2.2% had locomotive syndrome stage 2 and frailty, and 0.1% had sarcopenia and frailty. Locomotive syndrome stage 2, sarcopenia, and frailty alone, presented in 24.9%, 1.7%, and 0.2%, respectively. The remaining 64.0% had none of these conditions. Most subjects with sarcopenia and/or frailty also had locomotive syndrome. Preventing locomotive syndrome may help prevent frailty and sarcopenia and subsequent disability.This study aimed to estimate the prevalence of locomotive syndrome, sarcopenia, and frailty and clarify their co-existence in a population-based cohort. The third survey of Research on Osteoarthritis/Osteoporosis Against Disability (ROAD) study was conducted between 2012 and 2013, examining 963 subjects (aged ≥ 60 years; 321 men, 642 women). Locomotive syndrome, sarcopenia, and frailty were defined using three tests proposed by Japanese Orthopaedic Association, Asian Working Group for Sarcopenia criteria, and Fried's definition, respectively. Prevalence of locomotive syndrome stages 1 and 2 were 81.0% (men, 80.4%; women, 81.3%) and 34.1% (men, 30.5%; women, 35.8%), respectively, and those of sarcopenia and frailty were 8.7% (men, 9.7%; women, 8.3%) and 4.5% (men, 2.8%; women, 5.3%), respectively. Locomotive syndrome stage 1, sarcopenia, and frailty co-existed in 2.1%; 6.5% had locomotive syndrome stage 1 and sarcopenia, 2.4% had locomotive syndrome stage 1 and frailty, while none had sarcopenia and frailty. Locomotive syndrome stage 1 presented alone in 70.0%, sarcopenia in 0.1%, and no frailty. The remaining 18.9% had none of these conditions. Co-existence of locomotive syndrome stage 2, sarcopenia, and frailty was observed in 2.0%; 5.0% had locomotive syndrome stage 2 and sarcopenia, 2.2% had locomotive syndrome stage 2 and frailty, and 0.1% had sarcopenia and frailty. Locomotive syndrome stage 2, sarcopenia, and frailty alone, presented in 24.9%, 1.7%, and 0.2%, respectively. The remaining 64.0% had none of these conditions. Most subjects with sarcopenia and/or frailty also had locomotive syndrome. Preventing locomotive syndrome may help prevent frailty and sarcopenia and subsequent disability. |
Author | Muraki, Shigeyuki Yoshimura, Noriko Iidaka, Toshiko Oka, Hiroyuki Akune, Toru Nakamura, Kozo Tanaka, Sakae Horii, Chiaki Kawaguchi, Hiroshi |
Author_xml | – sequence: 1 givenname: Noriko orcidid: 0000-0002-6555-5782 surname: Yoshimura fullname: Yoshimura, Noriko email: yoshimuran-ort@h.u-tokyo.ac.jp organization: Department of Preventive Medicine for Locomotive Organ Disorders, 22nd Century Medical and Research Center, The University of Tokyo – sequence: 2 givenname: Shigeyuki surname: Muraki fullname: Muraki, Shigeyuki organization: Department of Preventive Medicine for Locomotive Organ Disorders, 22nd Century Medical and Research Center, The University of Tokyo – sequence: 3 givenname: Toshiko surname: Iidaka fullname: Iidaka, Toshiko organization: Department of Preventive Medicine for Locomotive Organ Disorders, 22nd Century Medical and Research Center, The University of Tokyo – sequence: 4 givenname: Hiroyuki surname: Oka fullname: Oka, Hiroyuki organization: Department of Medical Research and Management for Musculoskeletal Pain, 22nd Century Medical and Research Center, Faculty of Medicine, University of Tokyo – sequence: 5 givenname: Chiaki surname: Horii fullname: Horii, Chiaki organization: Department of Orthopaedic Surgery, Sensory and Motor System Medicine, Graduate School of Medicine, The University of Tokyo – sequence: 6 givenname: Hiroshi surname: Kawaguchi fullname: Kawaguchi, Hiroshi organization: Tokyo Neurological Center – sequence: 7 givenname: Toru surname: Akune fullname: Akune, Toru organization: National Rehabiliation Center for Persons with Disabilities – sequence: 8 givenname: Kozo surname: Nakamura fullname: Nakamura, Kozo organization: Towa Hospital – sequence: 9 givenname: Sakae surname: Tanaka fullname: Tanaka, Sakae organization: Department of Orthopaedic Surgery, Sensory and Motor System Medicine, Graduate School of Medicine, The University of Tokyo |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/31222550$$D View this record in MEDLINE/PubMed |
BookMark | eNp9kc1q3DAUhUVJaSZpX6CLIugmhbjRny27uyFJfyAwJbRrI0vXGQWPNJXkoX6jPmbkmbSFLLK4EhLfOfdyzwk6ct4BQm8p-UgJkRcxH1IUhDa5CGUFeYEWVPCyKCsijtCCNFQUtZTNMTqJ8Z4QKktJX6FjThljZUkW6M_3ADs1gNOAlTNY-wJ-25j2H77Hg9d-45PdAY6TM8Fv4BxHFbTfgrPqfC_qg7JDmj7htIZcNhgcx7CDaXa4hQiZX2Pv8CobexXSOthk48X-ufXBRxvx8k5ZFxO-slF1drBpwme3q-XVBxzTaKbX6GWvhghvHu9T9PPz9Y_Lr8XN6su3y-VNoUVVpqLrNYe6FFXdV40B1pWai64SveGCgaJSyKauoGZGd52UhtNSqF4DN7VgHev5KTo7-G6D_zVCTO3GRg3DoBz4MbaMibxdVosqo--foPd-DC5PN1O8zkwjMvXukRq7DZh2G-xGhan9m0EG2AHQeRExQP8PoaSdg24PQbc56HYfdDuL6icibZNK1rs0h_G8lB-kMfdxdxD-j_2M6gFN9b7_ |
CitedBy_id | crossref_primary_10_1177_23094990211060967 crossref_primary_10_2490_jjrmc_56_888 crossref_primary_10_1007_s10067_023_06639_z crossref_primary_10_1186_s41100_021_00352_w crossref_primary_10_1371_journal_pone_0269103 crossref_primary_10_1589_jpts_34_440 crossref_primary_10_1186_s12891_022_05738_3 crossref_primary_10_1016_j_jbmt_2023_04_031 crossref_primary_10_3389_fpsyt_2024_1464285 crossref_primary_10_34142_HSR_2023_09_01_05 crossref_primary_10_1186_s12891_020_03469_x crossref_primary_10_1186_s12891_023_06686_2 crossref_primary_10_1186_s12877_021_02440_2 crossref_primary_10_1111_ggi_15026 crossref_primary_10_1093_mr_roac101 crossref_primary_10_1016_j_ajoms_2020_04_005 crossref_primary_10_1016_j_jos_2022_11_021 crossref_primary_10_2490_jjrmc_58_605 crossref_primary_10_1111_ggi_14779 crossref_primary_10_2490_prm_20220014 crossref_primary_10_1007_s10147_023_02312_2 crossref_primary_10_3390_nu13051730 crossref_primary_10_3390_jcm12134345 crossref_primary_10_1186_s12891_020_03547_0 crossref_primary_10_12965_jer_2244234_117 crossref_primary_10_1016_j_bone_2022_116570 crossref_primary_10_1007_s43657_023_00122_0 crossref_primary_10_2139_ssrn_4191850 crossref_primary_10_31612_2616_4868_4_26__2023_01 crossref_primary_10_1002_ejp_2156 crossref_primary_10_1016_j_jos_2024_07_003 crossref_primary_10_1186_s12877_023_03828_y crossref_primary_10_3390_jcm12175626 crossref_primary_10_1589_jpts_33_362 crossref_primary_10_1111_ggi_14785 crossref_primary_10_1093_mr_roab024 crossref_primary_10_1080_14397595_2021_1899890 crossref_primary_10_1093_mr_roac039 crossref_primary_10_1371_journal_pone_0245879 crossref_primary_10_1111_jdi_13291 crossref_primary_10_37586_2686_8636_3_2021_364_370 crossref_primary_10_1016_j_jos_2020_06_012 crossref_primary_10_1111_ggi_14627 crossref_primary_10_1136_bmjopen_2022_068645 crossref_primary_10_1016_j_jocn_2023_08_012 crossref_primary_10_7759_cureus_64612 crossref_primary_10_1016_j_jos_2020_02_006 crossref_primary_10_1016_j_jos_2025_01_004 crossref_primary_10_1111_ggi_14273 crossref_primary_10_3390_jcm9041216 crossref_primary_10_1589_rika_36_623 crossref_primary_10_1038_s41598_023_46558_2 crossref_primary_10_1111_ggi_14593 crossref_primary_10_22603_ssrr_2021_0088 crossref_primary_10_1016_j_bbrc_2021_10_043 crossref_primary_10_1186_s40101_023_00334_3 crossref_primary_10_7717_peerj_9026 crossref_primary_10_1186_s12877_023_04405_z crossref_primary_10_1016_j_maturitas_2020_11_009 crossref_primary_10_1016_j_jos_2021_02_003 crossref_primary_10_2490_prm_20200029 crossref_primary_10_1093_heapro_daae164 crossref_primary_10_1093_mr_roac004 crossref_primary_10_1080_07399332_2022_2083620 crossref_primary_10_1002_jcsm_12870 crossref_primary_10_1186_s12891_021_04421_3 crossref_primary_10_3390_geriatrics7030069 crossref_primary_10_1590_1980_265x_tce_2020_0494 crossref_primary_10_36425_rehab630518 crossref_primary_10_1002_acr_24342 crossref_primary_10_3390_ijerph17197272 crossref_primary_10_1016_j_jos_2022_03_004 crossref_primary_10_1111_ggi_14162 crossref_primary_10_7717_peerj_12292 crossref_primary_10_1002_14651858_CD013088_pub2 crossref_primary_10_1038_s41514_024_00184_y crossref_primary_10_1186_s12891_025_08456_8 crossref_primary_10_1589_jpts_32_227 crossref_primary_10_23736_S0393_3660_23_04984_7 crossref_primary_10_37586_2686_8636_3_2024_225_239 crossref_primary_10_3390_ijerph19138164 crossref_primary_10_1007_s10067_022_06147_6 crossref_primary_10_1080_14397595_2020_1740411 crossref_primary_10_1016_j_afos_2021_10_001 crossref_primary_10_1093_mr_roaf002 crossref_primary_10_1093_mr_road025 crossref_primary_10_1111_1756_185X_15371 crossref_primary_10_1111_ggi_14924 |
Cites_doi | 10.1093/gerona/52A.3.M129 10.1111/j.1532-5415.2007.01140.x 10.1007/s00776-015-0741-5 10.1093/gerona/56.3.M146 10.1007/s00776-011-0193-5 10.1111/ggi.12397 10.1016/j.jamda.2013.11.025 10.1016/S0899-9007(01)00555-X 10.1093/ageing/afq034 10.1007/s00198-018-4596-4 10.1016/j.archger.2012.06.015 10.1007/s00776-007-1202-6 10.1093/ajcn/50.5.1231 10.1093/jn/127.5.990S 10.1093/gerona/61.10.1059 10.1016/S0899-9007(00)00553-0 10.1007/s00776-011-0160-1 10.1093/ageing/afy169 10.1093/ajcn/64.3.524S 10.1080/14397595.2016.1226471 10.1067/mlc.2001.113504 10.1007/s00774-009-0080-8 10.1152/jappl.2000.89.2.465 10.1007/s00198-016-3823-0 10.1093/ije/dyp276 10.1111/ggi.12037 |
ContentType | Journal Article |
Copyright | Springer Japan KK, part of Springer Nature 2019 Journal of Bone and Mineral Metabolism is a copyright of Springer, (2019). All Rights Reserved. |
Copyright_xml | – notice: Springer Japan KK, part of Springer Nature 2019 – notice: Journal of Bone and Mineral Metabolism is a copyright of Springer, (2019). All Rights Reserved. |
DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 3V. 7QP 7RV 7X7 7XB 88E 8AO 8FI 8FJ 8FK ABUWG AFKRA BENPR CCPQU FYUFA GHDGH K9. KB0 M0S M1P NAPCQ PHGZM PHGZT PJZUB PKEHL PPXIY PQEST PQQKQ PQUKI PRINS 7X8 |
DOI | 10.1007/s00774-019-01012-0 |
DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed ProQuest Central (Corporate) Calcium & Calcified Tissue Abstracts Nursing & Allied Health Database Health & Medical Collection ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) ProQuest Pharma Collection Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest Central UK/Ireland ProQuest Central ProQuest One Community College Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Health & Medical Complete (Alumni) Nursing & Allied Health Database (Alumni Edition) ProQuest Health & Medical Collection Medical Database Nursing & Allied Health Premium ProQuest Central Premium ProQuest One Academic ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China MEDLINE - Academic |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) ProQuest One Academic Middle East (New) ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest One Health & Nursing ProQuest Pharma Collection ProQuest Central China ProQuest Central Health Research Premium Collection Health and Medicine Complete (Alumni Edition) Health & Medical Research Collection ProQuest Central (New) ProQuest Medical Library (Alumni) ProQuest One Academic Eastern Edition ProQuest Nursing & Allied Health Source ProQuest Hospital Collection Health Research Premium Collection (Alumni) ProQuest Hospital Collection (Alumni) Nursing & Allied Health Premium ProQuest Health & Medical Complete ProQuest Medical Library ProQuest One Academic UKI Edition ProQuest Nursing & Allied Health Source (Alumni) ProQuest One Academic Calcium & Calcified Tissue Abstracts ProQuest One Academic (New) ProQuest Central (Alumni) MEDLINE - Academic |
DatabaseTitleList | ProQuest One Academic Middle East (New) MEDLINE - Academic MEDLINE |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database – sequence: 3 dbid: BENPR name: ProQuest Central url: https://www.proquest.com/central sourceTypes: Aggregation Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1435-5604 |
EndPage | 1066 |
ExternalDocumentID | 31222550 10_1007_s00774_019_01012_0 |
Genre | Journal Article |
GrantInformation_xml | – fundername: Ministry of Education, Culture, Sports, Science and Technology in Japan grantid: B26293139 – fundername: Japan Agency for Medical Research and Development grantid: 17gk0210007h0003 funderid: http://dx.doi.org/10.13039/100009619 – fundername: Japan Agency for Medical Research and Development grantid: 17gk0210007h0003 |
GroupedDBID | --- -53 -5E -5G -BR -EM -Y2 -~C .86 .VR 06C 06D 0R~ 0VY 1N0 1SB 2.D 203 28- 29K 29~ 2J2 2JN 2JY 2KG 2KM 2LR 2P1 2VQ 2~H 30V 3O- 3V. 4.4 406 408 409 40D 40E 53G 5GY 5QI 5VS 67Z 6NX 7RV 7X7 88E 8AO 8FI 8FJ 8TC 8UJ 95- 95. 95~ 96X AAAVM AABHQ AACDK AAHNG AAIAL AAJBT AAJKR AANXM AANZL AARHV AARTL AASML AATNV AATVU AAUYE AAWCG AAYIU AAYQN AAYTO AAYZH ABAKF ABBBX ABBXA ABDZT ABECU ABFTV ABHLI ABHQN ABIPD ABJNI ABJOX ABKCH ABKTR ABMNI ABMQK ABNWP ABPLI ABQBU ABQSL ABSXP ABTEG ABTKH ABTMW ABULA ABUWG ABWNU ABXPI ACAOD ACBXY ACDTI ACGFO ACGFS ACHSB ACHXU ACKNC ACMDZ ACMLO ACOKC ACOMO ACPIV ACPRK ACREN ACSNA ACUDM ACZOJ ADBBV ADHHG ADHIR ADIMF ADINQ ADJJI ADKNI ADKPE ADRFC ADTPH ADURQ ADYFF ADYOE ADZKW AEBTG AEFIE AEFQL AEGAL AEGNC AEJHL AEJRE AEKMD AEMSY AENEX AEOHA AEPYU AESKC AETLH AEVLU AEXYK AFBBN AFEXP AFKRA AFLOW AFQWF AFWTZ AFYQB AFZKB AGAYW AGDGC AGGDS AGJBK AGMZJ AGQEE AGQMX AGRTI AGWIL AGWZB AGYKE AHAVH AHBYD AHIZS AHKAY AHMBA AHSBF AHYZX AIAKS AIGIU AIIXL AILAN AITGF AJBLW AJRNO AKMHD ALIPV ALMA_UNASSIGNED_HOLDINGS ALWAN AMKLP AMTXH AMXSW AMYLF AMYQR AOCGG ARMRJ ASPBG AVWKF AXYYD AZFZN B-. BA0 BBWZM BDATZ BENPR BGNMA BKEYQ BPHCQ BSONS BVXVI CAG CCPQU COF CS3 CSCUP D-I DDRTE DL5 DNIVK DPUIP DU5 EBD EBLON EBS EIOEI EJD EMOBN EN4 ESBYG EX3 F5P FEDTE FERAY FFXSO FIGPU FINBP FNLPD FRRFC FSGXE FWDCC FYUFA G-Y G-Z GGCAI GGRSB GJIRD GNWQR GQ6 GQ7 GQ8 GRRUI GXS H13 HF~ HG5 HG6 HMCUK HMJXF HQYDN HRMNR HVGLF HZ~ I09 IHE IJ- IKXTQ IMOTQ IWAJR IXC IXD IXE IZIGR IZQ I~X I~Z J-C J0Z JBSCW JCJTX JZLTJ KDC KOV KOW KPH LAS LLZTM M1P M4Y MA- N2Q NAPCQ NB0 NDZJH NPVJJ NQJWS NU0 O9- O93 O9G O9I O9J OAM OVD P19 P2P P9S PF0 PQQKQ PROAC PSQYO PT4 PT5 QOK QOR QOS R4E R89 R9I RHV RIG RNI RNS ROL RPX RRX RSV RZK S16 S1Z S26 S27 S28 S37 S3B SAP SCLPG SDE SDH SDM SHX SISQX SJYHP SMD SNE SNPRN SNX SOHCF SOJ SPISZ SRMVM SSLCW SSXJD STPWE SV3 SZ9 SZN T13 T16 TEORI TSG TSK TSV TT1 TUC U2A U9L UG4 UKHRP UOJIU UTJUX UZXMN VC2 VFIZW W23 W48 WJK WK8 WOW YLTOR Z45 Z7U Z82 Z87 Z8O Z8V Z91 ZMTXR ZOVNA ~A9 ~EX ~KM AAPKM AAYXX ABBRH ABDBE ABFSG ACMFV ACSTC ADHKG AEZWR AFDZB AFHIU AFOHR AGQPQ AHPBZ AHWEU AIXLP ATHPR CITATION PHGZM PHGZT ABRTQ CGR CUY CVF ECM EIF NPM PJZUB PPXIY 7QP 7XB 8FK K9. PKEHL PQEST PQUKI PRINS 7X8 |
ID | FETCH-LOGICAL-c465t-bfc3e85468f69de2b5c34b64fd342ea1747986e82dcbb77d3154afce3d842b2f3 |
IEDL.DBID | U2A |
ISSN | 0914-8779 1435-5604 |
IngestDate | Fri Jul 11 16:26:21 EDT 2025 Fri Jul 25 04:58:28 EDT 2025 Mon Jul 21 05:52:48 EDT 2025 Tue Jul 01 04:35:23 EDT 2025 Thu Apr 24 23:05:08 EDT 2025 Fri Feb 21 02:37:38 EST 2025 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 6 |
Keywords | Disability Sarcopenia Frailty Co-existence Locomotive syndrome |
Language | English |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c465t-bfc3e85468f69de2b5c34b64fd342ea1747986e82dcbb77d3154afce3d842b2f3 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 |
ORCID | 0000-0002-6555-5782 |
PMID | 31222550 |
PQID | 2243884694 |
PQPubID | 1456336 |
PageCount | 9 |
ParticipantIDs | proquest_miscellaneous_2245602846 proquest_journals_2243884694 pubmed_primary_31222550 crossref_primary_10_1007_s00774_019_01012_0 crossref_citationtrail_10_1007_s00774_019_01012_0 springer_journals_10_1007_s00774_019_01012_0 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2019-11-01 |
PublicationDateYYYYMMDD | 2019-11-01 |
PublicationDate_xml | – month: 11 year: 2019 text: 2019-11-01 day: 01 |
PublicationDecade | 2010 |
PublicationPlace | Tokyo |
PublicationPlace_xml | – name: Tokyo – name: Japan |
PublicationTitle | Journal of bone and mineral metabolism |
PublicationTitleAbbrev | J Bone Miner Metab |
PublicationTitleAlternate | J Bone Miner Metab |
PublicationYear | 2019 |
Publisher | Springer Japan Springer Nature B.V |
Publisher_xml | – name: Springer Japan – name: Springer Nature B.V |
References | RoubenoffRBaumgartnerRNHarrisTBDallalGEHannanMTEconomosCDStauberPMWilsonPWKielDPApplication of bioelectrical impedance analysis to elderly populationsJ Gerontol A Biol Sci Med Sci199752M129M1361:STN:280:DyaK2szgt1WqsA%3D%3D10.1093/gerona/52A.3.M129 YoshimuraNMurakiSOkaHTanakaSOgataTKawaguchiHAkuneTNakamuraKAssociation between new indices in the locomotive syndrome risk test and decline in mobility: third survey of the ROAD studyJ Orthop Sci20152089690510.1007/s00776-015-0741-5 YoshimuraNMurakiSOkaHKawaguchiHNakamuraKAkuneTCohort profile: research on osteoarthritis/osteoporosis against disability (ROAD) studyInt J Epidemiol20103998899510.1093/ije/dyp276 National Institutes of HealthBioelectrical impedance analysis in body composition measurement: National Institutes of Health Technology Assessment Conference StatementAm J Clin Nutr199664524S532S10.1093/ajcn/64.3.524S NakamuraKA ‘super-aged’ society and the ‘locomotive syndrome’J Orthop Sci2008131210.1007/s00776-007-1202-6 ChenLKLiuLKWooJAssantachaiPAuyeungTWSarcopenia in Asia: consensus report of the Asian Working Group for SarcopeniaJ Am Med Dir Assoc2014159510110.1016/j.jamda.2013.11.025 Ministry of Health, Labour, and Welfare (2016) The outline of the results of National Livelihood Survey 2016. http://www.mhlw.go.jp/toukei/saikin/hw/k-tyosa/k-tyosa16/index.html GoodpasterBHParkSWHarrisTBKritchevskySBNevittMSchwartzAVSimonsickEMTylavskyFAVisserMNewmanABThe loss of skeletal muscle strength, mass, and quality in older adults: the health, aging and body composition studyJ Gerontol A Biol Sci Med Sci2006611059106410.1093/gerona/61.10.1059 Cruz-JentoftAJBaeyensJPBauerJMBoirieYCederholmTLandiFMartinFCMichelJPRollandYSchneiderSMTopinkováEVandewoudeMZamboniMEuropean Working Group on Sarcopenia in Older PeopleSarcopenia: European consensus on definition and diagnosis: Report of the European Working Group on Sarcopenia in Older PeopleAge Ageing20103941242310.1093/ageing/afq034 YoshimuraNMurakiSOkaHIidakaTKodamaRKawaguchiHNakamuraKTanakaSAkuneTIs osteoporosis a predictor for future sarcopenia, or vice versa? Four-year observations between the second and third ROAD study surveysOsteoporos Int2017281891991:STN:280:DC%2BC2sjgt1ersQ%3D%3D10.1007/s00198-016-3823-0 KyleUGGentonLKarsegardLSlosmanDOPichardCSingle prediction equation for bioelectrical impedance analysis in adults aged 20–94 yearsNutrition2001172482531:STN:280:DC%2BD3M3itFOjtQ%3D%3D10.1016/S0899-9007(00)00553-0 NemotoMYasbushitaNKimMMatsuoTSeinoSValidity of the bioelectrical impedance method for assessing body composition in non-frail and pre-frail older adultsInt J Body Comps Res2012105562 Locomotive syndromeLocomotive Challenge CouncilLocomotive syndrome pamphlet2015TokyoJapanese Orthopaedic Association(in Japanese) MorleyJEBaumgartnerRNRoubenoffRMayerJNairKSSarcopeniaJ Lab Clin Med20011372312431:STN:280:DC%2BD3M3gvVyrsg%3D%3D10.1067/mlc.2001.113504 JanssenIHeymsfieldSBBaumgartnerRNRossREstimation of skeletal muscle mass by bioelectrical impedance analysisJ Appl Physiol2000894654711:STN:280:DC%2BD3cvjslShsw%3D%3D10.1152/jappl.2000.89.2.465 KyleUGGentonLSlosmanDOPichardCFat-free and fat mass percentiles in 5225 healthy subjects aged 15 to 98 yearsNutrition2001175345411:STN:280:DC%2BD38%2Fit1Smuw%3D%3D10.1016/S0899-9007(01)00555-X RosenbergISummary comments: epidemiological and methodological problems in determining nutritional status of older personsAm J Clin Nutr1989501231123310.1093/ajcn/50.5.1231 DelmonicoMJHarrisTBLeeJSVisserMNevittMKritchevskySBTylavskyFANewmanABHealth, Aging and Body Composition StudyAlternative definitions of sarcopenia, lower extremity performance, and functional impairment with aging in older men and womenJ Am Geriatr Soc20075576977410.1111/j.1532-5415.2007.01140.x YoshimuraNMurakiSOkaHMabuchiAEn-yoYYoshidaMSaikaAYoshidaHSuzukiTYamamotoSIshibashiHKawaguchiHNakamuraKAkuneTPrevalence of knee osteoarthritis, lumbar spondylosis and osteoporosis in Japanese men and women: the research on osteoarthritis/osteoporosis against disability studyJ Bone Miner Metab20092762062810.1007/s00774-009-0080-8 RosenbergIHSarcopenia: origins and clinical relevanceJ Nutr1997127990S991S1:CAS:528:DyaK2sXjtVCnsro%3D10.1093/jn/127.5.990S AraiHSatakeSEnglish translation of the Kihon checklistGeriatr Gerontol Int20151551851910.1111/ggi.12397 FriedLPTangenCMWalstonJNewmanABHirschCGottdienerJSeemanTTracyRKopWJBurkeGMcBurnieMACardiovascular Health Study Collaborative Research GroupFrailty in older adults: evidence for a phenotypeJ Gerontol A Biol Sci Med Sci200156M146M1561:STN:280:DC%2BD3M7osFejuw%3D%3D10.1093/gerona/56.3.M146 Locomotive syndromeLocomotive Challenge CouncilLocomotive syndrome pamphlet2013TokyoJapanese Orthopaedic Association Cruz-JentoftAJBahatGBauerJBoirieYBruyèreOCederholmTCooperCLandiFRollandYSayerAASchneiderSMSieberCCTopinkovaEVandewoudeMVisserMZamboniMWriting Group for the European Working Group on Sarcopenia in Older People 2 (EWGSOP2)The Extended Group for EWGSOP2Sarcopenia: revised European consensus on definition and diagnosisAge Ageing201948163110.1093/ageing/afy169 TanimotoYWatanabeMSunWSugiuraYTsudaYKimuraMHayashidaIKusabirakiTKonoKAssociation between sarcopenia and higher-level functional capacity in daily living in community-dwelling elderly subjects in JapanArch Gerontol Geriatr201255e9e1310.1016/j.archger.2012.06.015 Ministry of Health, Labour, and Welfare. Health Japan 21 (the second term). https://www.mhlw.go.jp/file/06-Seisakujouhou-10900000-Kenkoukyoku/0000047330.pdf SeichiAHoshinoYDoiTAkaiMTobimatsuYIwayaTDevelopment of a screening tool for risk of locomotive syndrome in the elderly: the 25-question Geriatric Locomotive Function ScaleJ Orthop Sci20121716317210.1007/s00776-011-0193-5 YoshimuraNMurakiSOkaHIidakaTKodamaRHoriiCKawaguchiHNakamuraKAkuneTTanakaSDo sarcopenia and/or osteoporosis increase the risk of frailty? A four-year observation of the second and third ROAD study surveysOsteoporos Int201829218121901:CAS:528:DC%2BC1cXhtFyjtL3I10.1007/s00198-018-4596-4 TanimotoYWatanabeMSunWTanimotoKShishikuraKSugiuraYKusabirakiTKonoKAssociation of sarcopenia with functional decline in community-dwelling elderly subjects in JapanGeriatr Gerontol Int20131395896310.1111/ggi.12037 YoshimuraNOkaHMurakiSAkuneTHirabayashiNMatsudaSNojiriTHatanakaKIshimotoYNagataKYoshidaMTokimuraFKawaguchiHNakamuraKReference values for hand grip strength, muscle mass, walking time, and one-leg standing time as indices for locomotive syndrome and associated disability: the second survey of the ROAD studyJ Orthop Sci20111676877710.1007/s00776-011-0160-1 YoshimuraNMurakiSNakamuraKTanakaSEpidemiology of the locomotive syndrome: the research on osteoarthritis/osteoporosis against disability study 2005–2015Mod Rheumatol2017271710.1080/14397595.2016.1226471 I Rosenberg (1012_CR3) 1989; 50 JE Morley (1012_CR5) 2001; 137 N Yoshimura (1012_CR30) 2017; 27 N Yoshimura (1012_CR18) 2018; 29 UG Kyle (1012_CR23) 2001; 17 N Yoshimura (1012_CR16) 2011; 16 UG Kyle (1012_CR24) 2001; 17 Y Tanimoto (1012_CR26) 2012; 55 N Yoshimura (1012_CR15) 2010; 39 IH Rosenberg (1012_CR4) 1997; 127 N Yoshimura (1012_CR19) 2015; 20 M Nemoto (1012_CR28) 2012; 10 Locomotive syndrome (1012_CR13) 2015 I Janssen (1012_CR22) 2000; 89 Y Tanimoto (1012_CR27) 2013; 13 BH Goodpaster (1012_CR6) 2006; 61 R Roubenoff (1012_CR25) 1997; 52 1012_CR31 LP Fried (1012_CR2) 2001; 56 AJ Cruz-Jentoft (1012_CR9) 2019; 48 H Arai (1012_CR29) 2015; 15 K Nakamura (1012_CR11) 2008; 13 N Yoshimura (1012_CR17) 2017; 28 1012_CR1 LK Chen (1012_CR10) 2014; 15 N Yoshimura (1012_CR14) 2009; 27 MJ Delmonico (1012_CR7) 2007; 55 Locomotive syndrome (1012_CR12) 2013 A Seichi (1012_CR20) 2012; 17 National Institutes of Health (1012_CR21) 1996; 64 AJ Cruz-Jentoft (1012_CR8) 2010; 39 |
References_xml | – reference: Cruz-JentoftAJBaeyensJPBauerJMBoirieYCederholmTLandiFMartinFCMichelJPRollandYSchneiderSMTopinkováEVandewoudeMZamboniMEuropean Working Group on Sarcopenia in Older PeopleSarcopenia: European consensus on definition and diagnosis: Report of the European Working Group on Sarcopenia in Older PeopleAge Ageing20103941242310.1093/ageing/afq034 – reference: TanimotoYWatanabeMSunWSugiuraYTsudaYKimuraMHayashidaIKusabirakiTKonoKAssociation between sarcopenia and higher-level functional capacity in daily living in community-dwelling elderly subjects in JapanArch Gerontol Geriatr201255e9e1310.1016/j.archger.2012.06.015 – reference: Cruz-JentoftAJBahatGBauerJBoirieYBruyèreOCederholmTCooperCLandiFRollandYSayerAASchneiderSMSieberCCTopinkovaEVandewoudeMVisserMZamboniMWriting Group for the European Working Group on Sarcopenia in Older People 2 (EWGSOP2)The Extended Group for EWGSOP2Sarcopenia: revised European consensus on definition and diagnosisAge Ageing201948163110.1093/ageing/afy169 – reference: YoshimuraNMurakiSOkaHMabuchiAEn-yoYYoshidaMSaikaAYoshidaHSuzukiTYamamotoSIshibashiHKawaguchiHNakamuraKAkuneTPrevalence of knee osteoarthritis, lumbar spondylosis and osteoporosis in Japanese men and women: the research on osteoarthritis/osteoporosis against disability studyJ Bone Miner Metab20092762062810.1007/s00774-009-0080-8 – reference: DelmonicoMJHarrisTBLeeJSVisserMNevittMKritchevskySBTylavskyFANewmanABHealth, Aging and Body Composition StudyAlternative definitions of sarcopenia, lower extremity performance, and functional impairment with aging in older men and womenJ Am Geriatr Soc20075576977410.1111/j.1532-5415.2007.01140.x – reference: JanssenIHeymsfieldSBBaumgartnerRNRossREstimation of skeletal muscle mass by bioelectrical impedance analysisJ Appl Physiol2000894654711:STN:280:DC%2BD3cvjslShsw%3D%3D10.1152/jappl.2000.89.2.465 – reference: RosenbergIHSarcopenia: origins and clinical relevanceJ Nutr1997127990S991S1:CAS:528:DyaK2sXjtVCnsro%3D10.1093/jn/127.5.990S – reference: YoshimuraNMurakiSOkaHIidakaTKodamaRKawaguchiHNakamuraKTanakaSAkuneTIs osteoporosis a predictor for future sarcopenia, or vice versa? Four-year observations between the second and third ROAD study surveysOsteoporos Int2017281891991:STN:280:DC%2BC2sjgt1ersQ%3D%3D10.1007/s00198-016-3823-0 – reference: NemotoMYasbushitaNKimMMatsuoTSeinoSValidity of the bioelectrical impedance method for assessing body composition in non-frail and pre-frail older adultsInt J Body Comps Res2012105562 – reference: RoubenoffRBaumgartnerRNHarrisTBDallalGEHannanMTEconomosCDStauberPMWilsonPWKielDPApplication of bioelectrical impedance analysis to elderly populationsJ Gerontol A Biol Sci Med Sci199752M129M1361:STN:280:DyaK2szgt1WqsA%3D%3D10.1093/gerona/52A.3.M129 – reference: GoodpasterBHParkSWHarrisTBKritchevskySBNevittMSchwartzAVSimonsickEMTylavskyFAVisserMNewmanABThe loss of skeletal muscle strength, mass, and quality in older adults: the health, aging and body composition studyJ Gerontol A Biol Sci Med Sci2006611059106410.1093/gerona/61.10.1059 – reference: RosenbergISummary comments: epidemiological and methodological problems in determining nutritional status of older personsAm J Clin Nutr1989501231123310.1093/ajcn/50.5.1231 – reference: YoshimuraNMurakiSOkaHKawaguchiHNakamuraKAkuneTCohort profile: research on osteoarthritis/osteoporosis against disability (ROAD) studyInt J Epidemiol20103998899510.1093/ije/dyp276 – reference: YoshimuraNOkaHMurakiSAkuneTHirabayashiNMatsudaSNojiriTHatanakaKIshimotoYNagataKYoshidaMTokimuraFKawaguchiHNakamuraKReference values for hand grip strength, muscle mass, walking time, and one-leg standing time as indices for locomotive syndrome and associated disability: the second survey of the ROAD studyJ Orthop Sci20111676877710.1007/s00776-011-0160-1 – reference: KyleUGGentonLKarsegardLSlosmanDOPichardCSingle prediction equation for bioelectrical impedance analysis in adults aged 20–94 yearsNutrition2001172482531:STN:280:DC%2BD3M3itFOjtQ%3D%3D10.1016/S0899-9007(00)00553-0 – reference: YoshimuraNMurakiSNakamuraKTanakaSEpidemiology of the locomotive syndrome: the research on osteoarthritis/osteoporosis against disability study 2005–2015Mod Rheumatol2017271710.1080/14397595.2016.1226471 – reference: Locomotive syndromeLocomotive Challenge CouncilLocomotive syndrome pamphlet2015TokyoJapanese Orthopaedic Association(in Japanese) – reference: YoshimuraNMurakiSOkaHTanakaSOgataTKawaguchiHAkuneTNakamuraKAssociation between new indices in the locomotive syndrome risk test and decline in mobility: third survey of the ROAD studyJ Orthop Sci20152089690510.1007/s00776-015-0741-5 – reference: National Institutes of HealthBioelectrical impedance analysis in body composition measurement: National Institutes of Health Technology Assessment Conference StatementAm J Clin Nutr199664524S532S10.1093/ajcn/64.3.524S – reference: AraiHSatakeSEnglish translation of the Kihon checklistGeriatr Gerontol Int20151551851910.1111/ggi.12397 – reference: Ministry of Health, Labour, and Welfare (2016) The outline of the results of National Livelihood Survey 2016. http://www.mhlw.go.jp/toukei/saikin/hw/k-tyosa/k-tyosa16/index.html – reference: SeichiAHoshinoYDoiTAkaiMTobimatsuYIwayaTDevelopment of a screening tool for risk of locomotive syndrome in the elderly: the 25-question Geriatric Locomotive Function ScaleJ Orthop Sci20121716317210.1007/s00776-011-0193-5 – reference: TanimotoYWatanabeMSunWTanimotoKShishikuraKSugiuraYKusabirakiTKonoKAssociation of sarcopenia with functional decline in community-dwelling elderly subjects in JapanGeriatr Gerontol Int20131395896310.1111/ggi.12037 – reference: MorleyJEBaumgartnerRNRoubenoffRMayerJNairKSSarcopeniaJ Lab Clin Med20011372312431:STN:280:DC%2BD3M3gvVyrsg%3D%3D10.1067/mlc.2001.113504 – reference: Ministry of Health, Labour, and Welfare. Health Japan 21 (the second term). https://www.mhlw.go.jp/file/06-Seisakujouhou-10900000-Kenkoukyoku/0000047330.pdf) – reference: YoshimuraNMurakiSOkaHIidakaTKodamaRHoriiCKawaguchiHNakamuraKAkuneTTanakaSDo sarcopenia and/or osteoporosis increase the risk of frailty? A four-year observation of the second and third ROAD study surveysOsteoporos Int201829218121901:CAS:528:DC%2BC1cXhtFyjtL3I10.1007/s00198-018-4596-4 – reference: ChenLKLiuLKWooJAssantachaiPAuyeungTWSarcopenia in Asia: consensus report of the Asian Working Group for SarcopeniaJ Am Med Dir Assoc2014159510110.1016/j.jamda.2013.11.025 – reference: KyleUGGentonLSlosmanDOPichardCFat-free and fat mass percentiles in 5225 healthy subjects aged 15 to 98 yearsNutrition2001175345411:STN:280:DC%2BD38%2Fit1Smuw%3D%3D10.1016/S0899-9007(01)00555-X – reference: Locomotive syndromeLocomotive Challenge CouncilLocomotive syndrome pamphlet2013TokyoJapanese Orthopaedic Association – reference: FriedLPTangenCMWalstonJNewmanABHirschCGottdienerJSeemanTTracyRKopWJBurkeGMcBurnieMACardiovascular Health Study Collaborative Research GroupFrailty in older adults: evidence for a phenotypeJ Gerontol A Biol Sci Med Sci200156M146M1561:STN:280:DC%2BD3M7osFejuw%3D%3D10.1093/gerona/56.3.M146 – reference: NakamuraKA ‘super-aged’ society and the ‘locomotive syndrome’J Orthop Sci2008131210.1007/s00776-007-1202-6 – volume: 52 start-page: M129 year: 1997 ident: 1012_CR25 publication-title: J Gerontol A Biol Sci Med Sci doi: 10.1093/gerona/52A.3.M129 – volume: 55 start-page: 769 year: 2007 ident: 1012_CR7 publication-title: J Am Geriatr Soc doi: 10.1111/j.1532-5415.2007.01140.x – volume: 20 start-page: 896 year: 2015 ident: 1012_CR19 publication-title: J Orthop Sci doi: 10.1007/s00776-015-0741-5 – volume: 56 start-page: M146 year: 2001 ident: 1012_CR2 publication-title: J Gerontol A Biol Sci Med Sci doi: 10.1093/gerona/56.3.M146 – volume: 17 start-page: 163 year: 2012 ident: 1012_CR20 publication-title: J Orthop Sci doi: 10.1007/s00776-011-0193-5 – volume: 15 start-page: 518 year: 2015 ident: 1012_CR29 publication-title: Geriatr Gerontol Int doi: 10.1111/ggi.12397 – volume: 15 start-page: 95 year: 2014 ident: 1012_CR10 publication-title: J Am Med Dir Assoc doi: 10.1016/j.jamda.2013.11.025 – volume: 17 start-page: 534 year: 2001 ident: 1012_CR23 publication-title: Nutrition doi: 10.1016/S0899-9007(01)00555-X – volume: 39 start-page: 412 year: 2010 ident: 1012_CR8 publication-title: Age Ageing doi: 10.1093/ageing/afq034 – volume: 29 start-page: 2181 year: 2018 ident: 1012_CR18 publication-title: Osteoporos Int doi: 10.1007/s00198-018-4596-4 – volume: 55 start-page: e9 year: 2012 ident: 1012_CR26 publication-title: Arch Gerontol Geriatr doi: 10.1016/j.archger.2012.06.015 – volume: 13 start-page: 1 year: 2008 ident: 1012_CR11 publication-title: J Orthop Sci doi: 10.1007/s00776-007-1202-6 – volume-title: Locomotive syndrome pamphlet year: 2015 ident: 1012_CR13 – volume: 10 start-page: 55 year: 2012 ident: 1012_CR28 publication-title: Int J Body Comps Res – volume: 50 start-page: 1231 year: 1989 ident: 1012_CR3 publication-title: Am J Clin Nutr doi: 10.1093/ajcn/50.5.1231 – volume: 127 start-page: 990S year: 1997 ident: 1012_CR4 publication-title: J Nutr doi: 10.1093/jn/127.5.990S – volume: 61 start-page: 1059 year: 2006 ident: 1012_CR6 publication-title: J Gerontol A Biol Sci Med Sci doi: 10.1093/gerona/61.10.1059 – volume: 17 start-page: 248 year: 2001 ident: 1012_CR24 publication-title: Nutrition doi: 10.1016/S0899-9007(00)00553-0 – ident: 1012_CR1 – volume: 16 start-page: 768 year: 2011 ident: 1012_CR16 publication-title: J Orthop Sci doi: 10.1007/s00776-011-0160-1 – volume-title: Locomotive syndrome pamphlet year: 2013 ident: 1012_CR12 – volume: 48 start-page: 16 year: 2019 ident: 1012_CR9 publication-title: Age Ageing doi: 10.1093/ageing/afy169 – volume: 64 start-page: 524S year: 1996 ident: 1012_CR21 publication-title: Am J Clin Nutr doi: 10.1093/ajcn/64.3.524S – volume: 27 start-page: 1 year: 2017 ident: 1012_CR30 publication-title: Mod Rheumatol doi: 10.1080/14397595.2016.1226471 – volume: 137 start-page: 231 year: 2001 ident: 1012_CR5 publication-title: J Lab Clin Med doi: 10.1067/mlc.2001.113504 – volume: 27 start-page: 620 year: 2009 ident: 1012_CR14 publication-title: J Bone Miner Metab doi: 10.1007/s00774-009-0080-8 – volume: 89 start-page: 465 year: 2000 ident: 1012_CR22 publication-title: J Appl Physiol doi: 10.1152/jappl.2000.89.2.465 – volume: 28 start-page: 189 year: 2017 ident: 1012_CR17 publication-title: Osteoporos Int doi: 10.1007/s00198-016-3823-0 – volume: 39 start-page: 988 year: 2010 ident: 1012_CR15 publication-title: Int J Epidemiol doi: 10.1093/ije/dyp276 – volume: 13 start-page: 958 year: 2013 ident: 1012_CR27 publication-title: Geriatr Gerontol Int doi: 10.1111/ggi.12037 – ident: 1012_CR31 |
SSID | ssj0017571 |
Score | 2.5045578 |
Snippet | This study aimed to estimate the prevalence of locomotive syndrome, sarcopenia, and frailty and clarify their co-existence in a population-based cohort. The... |
SourceID | proquest pubmed crossref springer |
SourceType | Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 1058 |
SubjectTerms | Aged Arthritis Cohort Studies Disability Evaluation Female Frailty Frailty - complications Frailty - epidemiology Humans Male Medicine Medicine & Public Health Metabolic Diseases Original Article Orthopedics Osteoarthritis Osteoarthritis - complications Osteoarthritis - epidemiology Osteoporosis Osteoporosis - complications Osteoporosis - epidemiology Prevalence Sarcopenia Sarcopenia - complications Sarcopenia - epidemiology Surveys and Questionnaires Syndrome Young Adult |
SummonAdditionalLinks | – databaseName: Health & Medical Collection dbid: 7X7 link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3faxNBEF40QvFFrFaNxrKCDxWzNLnb-7G-SGgtRdBCMZC3Y3_Wg3JXc5dC_iP_TGc2exdKMA_3EO5uszCz932zO_MNIR9tBNNLkpxh0SfjAMlMacXZRCFcOYmbWJht8TO9nPPvi2QRNtyakFbZfRP9h9rUGvfITwFq4hzAUvCvd38Ydo3C09XQQuMxeYLSZejV2aIPuAAZfcAFkMhh1WciFM340jnUscH8C8wWmmB6wkNg2mGbOyelHoAunpNngTnS2cbUh-SRrV6Qgx_hbPwl-YtqTNLXEFFZGaprhjKXnhPT2lFALZ95d29pJ1Mwpg34OTbQKuXYv-SWsrxt118o8EK4yqWhzWp5b9c4QpelR-uKXsHANbjdby-KdOp_ApWvm7KhsxtZAuuk50G_t13Tk-ur2fkn6sVsj8j84tuvs0sW-jAwzdOkZcrp2OYJT3OXCmMjleiYq5Q7E3MwNcQ0mchTm0dGK5VlJgZaJp22scl5pCIXvyKDqq7sG0KdEDI3mRZpIiGynCrwlMhACCYMEFOhhmTaGaHQQaQce2XcFr28sjdcAYYrvOGKyZB87t-520h07H161Nm2CMu1KbbONSQf-tuw0PD0RFa2XvlngB0CmqdD8nrjE_3fxVMMmxMYfNw5yXbw_8_l7f65vCNPI3RQX_k4IoN2ubLvgQK16tj7-T92QQKP priority: 102 providerName: ProQuest |
Title | Prevalence and co-existence of locomotive syndrome, sarcopenia, and frailty: the third survey of Research on Osteoarthritis/Osteoporosis Against Disability (ROAD) study |
URI | https://link.springer.com/article/10.1007/s00774-019-01012-0 https://www.ncbi.nlm.nih.gov/pubmed/31222550 https://www.proquest.com/docview/2243884694 https://www.proquest.com/docview/2245602846 |
Volume | 37 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV3da9RAEB_6AeKL2NaP03qs4EPFC94lu0nWt7S9WixtpXhwPoX91EBJ5JIr3H_kn-nsXpIitUIfQgjZTBZmNvObzMxvAd6ZEKfHWBq4ps-AoksOpJI0GEvnrqxwP7FctcVFfDqjX-Zs3jaF1V21e5eS9F_qvtnNMc-4iglX3zN2BQWbsM0wdneFXLMw63MHCfNhFjpCims94W2rzL9l_O2O7mDMO_lR73ZOnsKTFi-SbK3gHdgw5S48Om8z4nvw23EwCd85RESpiaoCR27pkTCpLEFf5evtbgzpyAlGpEbrdttmFWLkH7ILUVw3q08E0SAexUKTerm4MSsnoavNI1VJLlFwhcb201MhffSXCOCruqhJ9kMUiDXJccva26zIwdVldvyeeArbZzA7mX47Og3a3RcCRWPWBNKqyKSMxqmNuTahZCqiMqZWRxQVjJFMwtPYpKFWUiaJjhCMCatMpFMaytBGz2GrrErzEojlXKQ6UTxmAuPJiUT7CDUGXlwjHOVyAJNOCblqqcndDhnXeU-q7BWXo-Jyr7h8PIAP_TO_1sQc_x293-k2bxdpnSN6iVLEX5wO4G1_G5eXy5mI0lRLPwYxIfrweAAv1jbRvy6auGCZofBRZyS3wu-fy6uHDX8Nj0NnsL7_cR-2msXSvEEg1MghbCbzZAjb2efvZ1M8H04vvl4N_Wr4AzzTA2E |
linkProvider | Springer Nature |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1ba9RQEB5qBe2LeO9q1SMoKG7o7snJTRBZXMvW3kBa2Ld4bmkDJambbGX_UZ_6G505m6RIsW99yENIMjnJTM58kzPzDcA7y3F4QRB7VPTpCXTJntJKeANF7iqT9BOLsi32w8mR-DENpitw2dbCUFplOye6idqUmv6Rb6Kr8WN0lon4evbbo65RtLrattBYmsWOXfzBkK36sj1G_b7nfOv74beJ13QV8LQIg9pTmfZtHIgwzsLEWK4C7QsVisz4AgeOCD1K4tDG3Gilosj4CDJkpq1vYsEVz3yUewfu4pMMKNiLpl2Ah57YBXjoggXOMlHSFOm4Uj3izaF8D8pOGlA6xL-O8Bq6vbYy6xze1kN40CBVNlqa1iNYscVjuLfXrMU_gQtif5KuZonJwjBdekSr6TA4KzOGXtJl-p1b1tIi9FmFL5AaduWy7y7KZjI_rRefGeJQ3PKZYdV8dm4XJKHNCmRlwQ5QcIlmfuJImDbdLoYOZZVXbHQsc0S5bNzwBdcL9uHnwWj8kTny3KdwdCsaegarRVnYdWBZksjYRDoJA4mR7FChZXKDIV9iEAgnqgfDVgmpbkjRqTfHadrROTvFpai41CkuHfTgU3fN2ZIS5MazN1rdps30UKVXxtyDt91h_LBptUYWtpy7cxCNInoIe_B8aRPd7fwhhekBCu-3RnIl_P9jeXHzWN7A_cnh3m66u72_8xLWOBmrq7rcgNV6NrevEH7V6rWzeQa_bvsj-wszkkB8 |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1baxNREB5qCsUX8W606hEUFLMk2T17E0SiaWitpqVY6Nv2XNuFsluzSSX_yN_gr3PmZHeLFPvWhzyE7E5OMnPOfLMz8w3Aa-Pj8sIw8ajp0-Pokj2pJPcGktyVFfQQi6otptH2If96FB6twZ-mF4bKKpsz0R3UulT0jLyPriZI0FmmvG_rsoj98eTT-U-PJkhRprUZp7EykV2z_IXhW_VxZ4y6fuP7k60fX7a9esKAp3gUzj1pVWCSkEeJjVJtfBmqgMuIWx1w_BGI1uM0iUziayVlHOsAAYewygQ64b70bYByb8F6TFFRB9Y_b033D9ocRhy6cA8dMsczJ07rlh3XuEcsOlT9QbVKAyqO-NctXsG6V_K0zv1N7sKdGrey0crQ7sGaKe7Dxvc6M_8AfhMXlHAdTEwUmqnSI5JNh8hZaRn6TFf3d2FYQ5LQYxX-hTS-Kxc9d5OdifxsvvzAEJXiK59pVi1mF2ZJEpoaQVYWbA8Fl2j0p46Sqe_eYiBRVnnFRiciR8zLxjV78HzJ3h7sjcbvmKPSfQiHN6KjR9ApysI8AWbTVCQ6VmkUCoxrhxLt1NcYAKYaYXEquzBslJCpmiKdJnWcZS25s1NchorLnOKyQRfet_ecrwhCrr16s9FtVh8WVXZp2l141X6M25xyN6Iw5cJdg9gUsUTUhccrm2i_LhhS0B6i8F5jJJfC_7-Wp9ev5SVs4AbLvu1Md5_BbZ9s1bVgbkJnPluY54jF5vJFbfQMjm96n_0FpHpGFw |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Prevalence+and+co-existence+of+locomotive+syndrome%2C+sarcopenia%2C+and+frailty%3A+the+third+survey+of+Research+on+Osteoarthritis%2FOsteoporosis+Against+Disability+%28ROAD%29+study&rft.jtitle=Journal+of+bone+and+mineral+metabolism&rft.au=Yoshimura%2C+Noriko&rft.au=Muraki%2C+Shigeyuki&rft.au=Iidaka%2C+Toshiko&rft.au=Oka%2C+Hiroyuki&rft.date=2019-11-01&rft.pub=Springer+Japan&rft.issn=0914-8779&rft.eissn=1435-5604&rft.volume=37&rft.issue=6&rft.spage=1058&rft.epage=1066&rft_id=info:doi/10.1007%2Fs00774-019-01012-0&rft.externalDocID=10_1007_s00774_019_01012_0 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0914-8779&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0914-8779&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0914-8779&client=summon |